微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.41% | -89.95% | 241.67% | 109/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.12% | 105.24% | 0% | 113/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.12% | 102.73% | 104.63% | 116/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -2.59% | -859.26% | -163.48% | 112/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.08% | 138.42% | 278.17% | 80/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -2.29% | 69.55% | 47.95% | 125/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -4.4% | -104.65% | -1529.63% | 137/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -0.27% | -115.52% | 97.46% | 111/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -10.62% | -1101.89% | -41.22% | 131/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -7.52% | 10.16% | -249.77% | 139/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -2.15% | -157.18% | -223.56% | 128/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.74% | -89.8% | 64.15% | 101/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 1.06% | -97.21% | 112.66% | 112/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -8.37% | -135.71% | -322.61% | 136/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.76% | -78.95% | -77.96% | 28/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 17.06% | 104.43% | -55.11% | 30/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 38% | 222.9% | 62.12% | 2/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 23.44% | 414.63% | 31.24% | 2/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 17.86% | 971.22% | 104.63% | 2/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -385.51% | -259.75% | -1146.8% | 137/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | -30.92% | -39.53% | -315.03% | 106/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | -7.45% | 54.21% | -263.41% | 114/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | -2.05% | 31.44% | 98.09% | 105/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -107.16% | -9500% | -383.57% | 134/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | -22.16% | -2230.77% | -36.2% | 101/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | -16.27% | -2811.67% | -444.15% | 105/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | -2.99% | -49.5% | -362.28% | 99/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 1.14% | -76.05% | 9.62% | 114/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.04% | -73.06% | 73.33% | 92/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 0.6% | -85.15% | 130% | 97/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | -2% | -213.64% | -142.02% | 88/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 4.76% | -23.1% | 23.32% | 85/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.86% | 343.68% | -4.46% | 58/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.04% | 425.81% | 129.55% | 48/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.76% | 145.83% | -71.57% | 47/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 6.19% | 177.58% | 611.49% | 68/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 0.87% | 120.81% | 170.16% | 67/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | -1.24% | 34.04% | 67.71% | 78/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | -3.84% | -67.69% | -272.2% | 74/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |